Hepatoma Research
OAE Publishing Inc. · United States · Est. 2015
✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3 · Scopus CiteScore 3.5. Source: Clarivate Journal Citation Reports.
Aims & Scope
Hepatoma Research is an international, open-access journal dedicated to the rapid publication of significant findings in the field of hepatoma (liver cancer). It covers a wide range of topics including hepatocellular carcinoma (HCC), liver cancer, liver tumors, hepatoblastoma, cholangiocarcinoma, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), hepatitis B, hepatitis C, immunotherapy, systemic treatment, liver transplantation, liver resection, surgical management, surveillance, epidemiology, molecular mechanisms, tumor microenvironment, biomarkers, and stem cell research.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Hepatoma Research
Is Hepatoma Research a predatory journal?
PubScope has no integrity flags on record for Hepatoma Research: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 62/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Hepatoma Research?
Hepatoma Research is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 3.5.
Is Hepatoma Research indexed in Scopus and Web of Science?
Hepatoma Research is indexed in Web of Science, Scopus.
What is the aims and scope of Hepatoma Research?
Hepatoma Research is an international, open-access journal dedicated to the rapid publication of significant findings in the field of hepatoma (liver cancer). It covers a wide range of topics including hepatocellular carcinoma (HCC), liver cancer, liver tumors, hepatoblastoma, cholangiocarcinoma, nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), hepatitis B, hepatitis C, immunotherapy, systemic treatment, liver transplantation, liver resection, surgical management, surveillance, epidemiology, molecular mechanisms, tumor microenvironment, biomarkers, and stem cell r
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref